Clinical trial · Interventional
A Novel Lung Function Imaging Modality As a Preoperative Evaluation Tool (LIME)
NCT03426306CI-TRIAL-00080802completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To evaluate the correlation between pre-surgical 4DCT-ventilation imaging and post-surgical lung function.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 4DCT-Ventilation | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- 4DCT-ventilation
- description
- The patient will undergo 4DCT imaging. The 4DCT imaging data along with image processing techniques will be used to generate a 4DCT-ventilation map. All surgical decisions will be based on the current standard of care imaging (VQ scans) and not on the 4DCT imaging results.
- interventionNames
- Diagnostic Test: 4DCT-Ventilation
Primary outcomes (1)
- measure
- Pre-Surgical Imaging and Post-Surgical Lung Function
- timeFrame
- Baseline visit to follow up visit, up to 9 months.
- description
- Measure the correlation between pre-surgical 4-Dimensional Computed Tomography-ventilation (4DCT) imaging and post surgical lung function using a Percent Predicted Post-Operative Pulmonary Function Test (%PPO PFT).
Secondary outcomes (4)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: 1. Provision to sign and date the consent form. 2. Stated willingness to comply with all required (non-optional) study procedures and be available for the duration of the study. 3. Be a male or female aged 18 to 100. 4. Patient with lung cancer (presumed or biopsy proven) currently undergoing or having undergone evaluation for resection. 5. Lung function assessment required for pre-surgical evaluation at the discretion of the cardiothoracic surgeon. 6. Life expectancy greater than 3 months. Exclusion Criteria: 1\. Patients getting a planned wedge resection as the only thoracic resectional procedure.
References
Publications (0)
Data not yet available
No reference posted for this study.